Company: ZURA
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0001410578-25-000443
Chunk: 7

Company: Zura Bio Ltd
Filing Date: 2025-03-25
Form: 10-K
Item: Item 1A
Chunk 7
---
 depend on license agreements with Pfizer and Lilly to permit us to use certain patents, know-how and technology. Termination of these rights or the failure to comply with obligations under these agreements could materially harm our business and prevent us from developing or commercializing the ZB Assets.

●Our ability to protect our patents and other proprietary rights is uncertain.  We have limited geographical protection with respect to our licensed patents and may not be able to protect our intellectual property rights throughout the world.  Patent terms may not protect our competitive position with respect to the ZB Assets for an adequate amount of time.  If we do not obtain patent term extension in the United States under the Hatch-Waxman Act and in foreign countries under similar legislation, our business may be materially harmed.